CVS Health Corporation (CVS)
CVS Health Statistics
Share Statistics
CVS Health has 1.26B shares outstanding. The number of shares has increased by 0.43% in one year.
| Shares Outstanding | 1.26B |
| Shares Change (YoY) | 0.43% |
| Shares Change (QoQ) | 0.19% |
| Owned by Institutions (%) | 82.92% |
| Shares Floating | 1.26B |
| Failed to Deliver (FTD) Shares | 4 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 20.55M, so 1.63% of the outstanding shares have been sold short.
| Short Interest | 20.55M |
| Short % of Shares Out | 1.63% |
| Short % of Float | 1.63% |
| Short Ratio (days to cover) | 2.15 |
Valuation Ratios
The PE ratio is 12.25 and the forward PE ratio is 10.02. CVS Health's PEG ratio is -0.28.
| PE Ratio | 12.25 |
| Forward PE | 10.02 |
| PS Ratio | 0.15 |
| Forward PS | 0.2 |
| PB Ratio | 0.75 |
| P/FCF Ratio | 8.93 |
| PEG Ratio | -0.28 |
Enterprise Valuation
CVS Health has an Enterprise Value (EV) of 130.85B.
| EV / Sales | 0.35 |
| EV / EBITDA | 9.55 |
| EV / EBIT | 14.37 |
| EV / FCF | 20.68 |
Financial Position
The company has a current ratio of 0.81, with a Debt / Equity ratio of 1.1.
| Current Ratio | 0.81 |
| Quick Ratio | 0.6 |
| Debt / Equity | 1.1 |
| Debt / EBITDA | 6.05 |
| Debt / FCF | 13.11 |
| Interest Coverage | 2.88 |
Financial Efficiency
Return on Equity is 6.11% and Return on Invested Capital is 3.61%.
| Return on Equity | 6.11% |
| Return on Assets | 1.82% |
| Return on Invested Capital | 3.61% |
| Revenue Per Employee | $1.7M |
| Profits Per Employee | $21.07K |
| Employee Count | 219,000 |
| Asset Turnover | 1.47 |
| Inventory Turnover | 17.75 |
Taxes
| Income Tax | 1.56B |
| Effective Tax Rate | 25.41% |
Stock Price Statistics
The stock price has increased by -0.32% in the last 52 weeks. The beta is 0.57, so CVS Health's price volatility has been higher than the market average.
| Beta | 0.57 |
| 52-Week Price Change | -0.32% |
| 50-Day Moving Average | 64.67 |
| 200-Day Moving Average | 58.54 |
| Relative Strength Index (RSI) | 58.98 |
| Average Volume (20 Days) | 13.12M |
Income Statement
In the last 12 months, CVS Health had revenue of 372.81B and earned 4.61B in profits. Earnings per share was 3.66.
| Revenue | 372.81B |
| Gross Profit | 51.4B |
| Operating Income | 8.52B |
| Net Income | 4.61B |
| EBITDA | 13.7B |
| EBIT | 9.11B |
| Earnings Per Share (EPS) | 3.66 |
Balance Sheet
The company has 8.59B in cash and 82.92B in debt, giving a net cash position of -74.33B.
| Cash & Cash Equivalents | 8.59B |
| Total Debt | 82.92B |
| Net Cash | -74.33B |
| Retained Earnings | 62.84B |
| Total Assets | 253.22B |
| Working Capital | -15.96B |
Cash Flow
In the last 12 months, operating cash flow was 9.11B and capital expenditures -2.78B, giving a free cash flow of 6.33B.
| Operating Cash Flow | 9.11B |
| Capital Expenditures | -2.78B |
| Free Cash Flow | 6.33B |
| FCF Per Share | 5.02 |
Margins
Gross margin is 13.79%, with operating and profit margins of 2.28% and 1.24%.
| Gross Margin | 13.79% |
| Operating Margin | 2.28% |
| Pretax Margin | 1.65% |
| Profit Margin | 1.24% |
| EBITDA Margin | 3.68% |
| EBIT Margin | 2.28% |
| FCF Margin | 1.7% |
Dividends & Yields
CVS pays an annual dividend of $3.33, which amounts to a dividend yield of 3.84%.
| Dividend Per Share | $3.33 |
| Dividend Yield | 3.84% |
| Dividend Growth (YoY) | 0% |
| Payout Ratio | 90.85% |
| Earnings Yield | 8.16% |
| FCF Yield | 11.19% |
Analyst Forecast
The average price target for CVS is $74, which is 7.5% higher than the current price. The consensus rating is "Buy".
| Price Target | $74 |
| Price Target Difference | 7.5% |
| Analyst Consensus | Buy |
| Analyst Count | 17 |
Stock Splits
The last stock split was on Jun 7, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 7, 2005 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 2.16 |
| Piotroski F-Score | 6 |